Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vanda Pharmaceuticals Inc. Director's Dealing 2009

Dec 16, 2009

33390_dirs_2009-12-16_0e0eb2a5-bd5e-4896-9e7a-b1bcf83303d4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2009-12-14

Reporting Person: Clark William D (Sr. VP, Chief Business Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-12-14 Common Stock M 36444 $0.331 Acquired 111444 Direct
2009-12-14 Common Stock M 8424 $0.331 Acquired 119868 Direct
2009-12-14 Common Stock M 45141 $0.331 Acquired 165009 Direct
2009-12-14 Common Stock M 57766 $0.331 Acquired 222775 Direct
2009-12-14 Common Stock M 147775 $0.331 Acquired 370550 Direct
2009-12-14 Common Stock S 217749 $11.0514 Disposed 152801 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-12-14 Employee Stock Option (right to buy) $0.331 M 36444 Disposed 2014-09-01 Common Stock (36444) Direct
2009-12-14 Employee Stock Option (right to buy) $0.331 M 8424 Disposed 2014-09-01 Common Stock (8424) Direct
2009-12-14 Employee Stock Option (right to buy) $0.331 M 45141 Disposed 2015-02-10 Common Stock (45141) Direct
2009-12-14 Employee Stock Option (right to buy) $0.331 M 57766 Disposed 2015-09-28 Common Stock (57766) Direct
2009-12-14 Employee Stock Option (right to buy) $0.331 M 147775 Disposed 2015-09-28 Common Stock (147775) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: The option represents a right to purchase a total of 91,668 shares. As of December 14, 2009 these shares were fully vested.

F3: The option represents a right to purchase a total of 48,341 shares. As of December 14, 2009 these shares were fully vested.

F4: The option represents a right to purchase a total of 205,541 shares. As of December 14, 2009 these shares were fully vested.